Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma

Cancer Chemother Rep. Jul-Aug 1975;59(4):761-3.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Clinical Trials as Topic
  • Colonic Neoplasms / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Razoxane / adverse effects
  • Razoxane / therapeutic use*
  • Rectal Neoplasms / drug therapy*

Substances

  • Piperazines
  • Razoxane